cancer immunotherapy | pharmaphorum

Friday 22 November 2024

Channels

Content type

Categories

Categories

Sort by

Order

cancer immunotherapy

News

iStock 599145902bac

PureTech licenses 'bacterial cocktail' to boost cancer immun...

PureTech Health is to develop a combination of a microbiome treatment with checkpoint inhibitor immunotherapy to enhance the effect of the cancer drugs.

News

KEYTRUDA is a prescription medicine used to treat a kind of skin cancer called melanoma

Keytruda 100mg/4mL Vial and Carton
2015

Merck & Co pulls Keytruda lung cancer filing in Europe

Blow for Merck as Keytruda sales top $1 billion per quarter.

News

OpdivoLarge

BMS scores an early victory in the new cancer biomarker batt...

Bristol-Myers Squibb is hoping to drive forward its Opdivo cancer immunotherapy franchise by finding a better biomarker than PD-L1 - and has just produced encouraging results in a trial loo

News

Roche Rituxan approval

Roche hopes blood test will predict immunotherapy efficacy

Test could help determine which patients respond to immunotherapies.

News

FDA building

FDA probes blood cancer immunotherapy safety

Regulator reviewing combination therapy safety after issue with Keytruda

News

BMS_Nassau_Park

BMS snaps up cancer biotech IFM in $2.3bn deal

BMS will gain rights to preclinical cancer immunotherapy drugs.